Abstract
A study of the genetic association between schizophrenia and aBalI polymorphism in exon 1 of the dopamine D3 (DRD3) gene, a candidate gene for schizophrenia, was conducted. The polymorphism was examined in 91 patients whose symptoms satisfied DSM-III-R for schizophrenia and 90 controls. There were no significant differences between the groups in allele frequencies or genotype counts. Contrary to a previous report, the patients were no more likely to be homozygous than controls. Moreover, no association with the presence of illness could be demonstrated when the patients were grouped according to sex, age of onset, history of admission to psychiatric institutions or positive family history.
Similar content being viewed by others
References
Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179–186
Cohen J (1988) Statistical power analysis for the behavioral sciences. Laurence Erlbaum Associate, New Jersey, pp 215–272
Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier D, Lannfelt L, Sokoloff P, Schwartz JC, Gill M, Macher JP, McGuffin P, Owen MJ (1992) Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29:858–860
Giros B, Martres MP, Sokoloff P, Schwarz JC (1990) Clonage du gene du recepteur dopaminergique D3 humain et identification de son chromosome. C R Acad Sci III 311:501–508
Gottesman II (1991) Schizophrenia genesis. Freeman, New York
Lannfelt L, Sokoloff P, Martres MP, Pilon C, Giros B, Jonsson E, Sedvall G, Schwartz JC (1992) Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr Genet 2:249–256
Le Coniat M, Sokoloff P, Hillion J, Matres MP, Giros B, Pilon C, Schwarz JC, Berger R (1991) Chromosomal localization of the human D3 dopamine receptor gene. Hum Genet 87:618–620
Seeman P (1981) Brain dopamine receptor. Pharmacol Rev 32:229–313
Sobell JL, Heston LL, Sommer SS (1992) Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics 12:1–6
Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwarz JC (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146–151
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nanko, S., Sasaki, T., Fukuda, R. et al. A study of the association between schizophrenia and the dopamine D3 receptor gene. Hum Genet 92, 336–338 (1993). https://doi.org/10.1007/BF01247330
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01247330